Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model
- 2022-07-09
- Clinical Trial
- Microorganisms 10(7)
- N. Iyer
- Michelle A Williams
- A. O’Callaghan
- E. Dempsey
- R. Cabrera-Rubio
- Mathilde Raverdeau
- F. Crispie
- P. Cotter
- S. Corr
- PubMed: 35889102
- DOI: 10.3390/microorganisms10071383
- Low evidence
- Rigorous Journal
- Animal Study
- Clinical
the recovery of microbiome-associated dysbiosis with an increased abundance of beneficial commensal species.
- Effect
- Beneficial
- Effect size
- Moderate